JACC: Basic to Translational Science (Dec 2018)

Hydrogen Sulfide Attenuates Renin Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney Function and Improve Exercise Tolerance in Heart Failure

  • Zhen Li, BS,
  • Chelsea L. Organ, PhD,
  • Jianming Kang, PhD,
  • David J. Polhemus, PhD,
  • Rishi K. Trivedi, PhD,
  • Thomas E. Sharp, III, PhD,
  • Jack S. Jenkins,
  • Ya-xiong Tao, PhD,
  • Ming Xian, PhD,
  • David J. Lefer, PhD

Journal volume & issue
Vol. 3, no. 6
pp. 796 – 809

Abstract

Read online

Summary: Cardioprotective effects of H2S have been well documented. However, the lack of evidence supporting the benefits afforded by delayed H2S therapy warrants further investigation. Using a murine model of transverse aortic constriction-induced heart failure, this study showed that delayed H2S therapy protects multiple organs including the heart, kidney, and blood-vessel; reduces oxidative stress; attenuates renal sympathetic and renin-angiotensin-aldosterone system pathological activation; and ultimately improves exercise capacity. These findings provide further insights into H2S-mediated cardiovascular protection and implicate the benefits of using H2S-based therapies clinically for the treatment of heart failure. Key Words: cardiorenal syndrome, exercise tolerance, heart failure, hydrogen sulfide, RAAS